Lentuo International Inc (ADR) (LAS), Nam Tai Electronics, Inc. (NTE), China Hgs Real Estate Inc (HGSH) Among The Top Five Losers On Monday

Editor’s note: Related tickers: Lentuo International Inc (ADR) (NYSE:LAS),  Nam Tai Electronics, Inc. (NYSE:NTE), China Hgs Real Estate Inc (NASDAQ:HGSH), Greenway Medical Technologies, Inc. (NYSE:GWAY), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

Even though there are price gainers and volume leaders, the top losers must also be watched. On Monday, the top five losers are: Lentuo International Inc (ADR) (NYSE:LAS),  Nam Tai Electronics, Inc. (NYSE:NTE), China Hgs Real Estate Inc (NASDAQ:HGSH), Greenway Medical Technologies, Inc. (NYSE:GWAY), and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX),

Lentuo International Inc (ADR) (NYSE:LAS) slid by 31.30% to $1.80 in deals worth $370,900. According to a statement on PRNewswire, Lentuo International Inc (ADR) (NYSE:LAS) today posted the financial results for the fourth quarter of 2012 and for the entire last year. The revenue in the fourth quarter fell by 15.4% on the year to $140.8 million, while the net loss totalled $3.9 million, compared to a profit of $2.5 million. Over the whole 2012, the revenue grew by 7.5% to $524.1 million, the statement added.

Nam Tai Electronics, Inc. (NYSE:NTE)

In turnover worth almost $7.4 million, Nam Tai Electronics, Inc. (NYSE:NTE) has lost 29.48% to $7.99. Today, Nam Tai Electronics, Inc. (NYSE:NTE) released its financial results for the first three months of 2013. The net sales advanced to $177.5 million, higher compared to $87.8 million in the first quarter of the previous year. The net income totalled almost $5.0 million, against a loss of $3.6 million, Nam Tai Electronics, Inc. (NYSE:NTE) said in a statement.

China Hgs Real Estate Inc (NASDAQ:HGSH) declined by 25.51% to $9.11. China Hgs Real Estate Inc (NASDAQ:HGSH) is specialized in real estate development, construction and sale of residential apartments, parking as well as commercial properties.

Greenway Medical Technologies, Inc. (NYSE:GWAY) fell by 19.07% to $12.99 in turnover of about $887,900.  In a statement issued today, Greenway Medical Technologies, Inc. (NYSE:GWAY), has reviewed its outlook for the fiscal year that will end on June 30, 2013. The company forecasts a revenue between $132 million and $134 million and an adjusted EBITDA of between %5.8 million to $6.8 million.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) decreased by 18.86% to $1.85 in deals worth $3.2 million. The Street said in a story today that  Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) could suffer after Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE) announced about signing a partnership agreement for the development of Pfizer Inc. (NYSE:PFE)’s ertugliflozin which is being evaluated for the cure of type 2 diabetes. Since Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is designing a similar drug, LX4211, it could have some difficulties finding a partner to help cover the costs of research, The Street said.

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

The 20 Biggest Contracts in MLB History

The 7 Worst Blown Calls in Sports History

7 Free Ways to Advertise Your Business Online

The 18 Best R&B Songs of the 90’s

The 10 Most Dangerous States to be a Cop

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!